377 related articles for article (PubMed ID: 33291312)
1. Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals.
Zeb A; Rana I; Choi HI; Lee CH; Baek SW; Lim CW; Khan N; Arif ST; Sahar NU; Alvi AM; Shah FA; Din FU; Bae ON; Park JS; Kim JK
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33291312
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in pulmonary delivery of biopharmaceuticals.
Kunde SS; Ghosh R; Wairkar S
Drug Discov Today; 2022 May; 27(5):1474-1482. PubMed ID: 35143963
[TBL] [Abstract][Full Text] [Related]
3. Formulation strategies and particle engineering technologies for pulmonary delivery of biopharmaceuticals.
Cun D; Wan F; Yang M
Curr Pharm Des; 2015; 21(19):2599-610. PubMed ID: 25876915
[TBL] [Abstract][Full Text] [Related]
4. Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications.
Alwani S; Wasan EK; Badea I
Mol Pharm; 2024 Jul; 21(7):3084-3102. PubMed ID: 38828798
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.
Mitragotri S; Burke PA; Langer R
Nat Rev Drug Discov; 2014 Sep; 13(9):655-72. PubMed ID: 25103255
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles for the delivery of biopharmaceuticals.
Silva AC; Amaral MH; Lobo JM; Lopes CM
Curr Pharm Biotechnol; 2015; 16(4):291-302. PubMed ID: 25601601
[TBL] [Abstract][Full Text] [Related]
7. Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus.
Munsell EV; Ross NL; Sullivan MO
Curr Pharm Des; 2016; 22(9):1227-44. PubMed ID: 26675220
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery.
Madani F; Hsein H; Busignies V; Tchoreloff P
Pharm Dev Technol; 2020 Feb; 25(2):133-148. PubMed ID: 31690146
[TBL] [Abstract][Full Text] [Related]
10. Skin penetration/permeation success determinants of nanocarriers: Pursuit of a perfect formulation.
Elmowafy M
Colloids Surf B Biointerfaces; 2021 Jul; 203():111748. PubMed ID: 33853001
[TBL] [Abstract][Full Text] [Related]
11. Formulations strategies for biopharmaceuticals--ensuring success to market.
Atkinson EM; Klum W
IDrugs; 2001 May; 4(5):557-60. PubMed ID: 16012901
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications.
Yu YQ; Yang X; Wu XF; Fan YB
Front Bioeng Biotechnol; 2021; 9():646554. PubMed ID: 33855015
[TBL] [Abstract][Full Text] [Related]
13. Biopharmaceutical nanoclusters: Towards the self-delivery of protein and peptide therapeutics.
Danielsen M; Hempel C; Andresen TL; Urquhart AJ
J Control Release; 2022 Jul; 347():282-307. PubMed ID: 35513210
[TBL] [Abstract][Full Text] [Related]
14. From cell factories to patients: Stability challenges in biopharmaceuticals manufacturing and administration with mitigation strategies.
Elsayed A; Jaber N; Al-Remawi M; Abu-Salah K
Int J Pharm; 2023 Oct; 645():123360. PubMed ID: 37657507
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
Witting M; Obst K; Friess W; Hedtrich S
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
[TBL] [Abstract][Full Text] [Related]
16. Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.
Farinha S; Sá JV; Lino PR; Galésio M; Pires J; Rodrigues MÂ; Henriques J
Pharm Res; 2023 May; 40(5):1115-1140. PubMed ID: 36456666
[TBL] [Abstract][Full Text] [Related]
17. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery.
Wang H; Qin L; Zhang X; Guan J; Mao S
J Control Release; 2022 Dec; 352():970-993. PubMed ID: 36372386
[TBL] [Abstract][Full Text] [Related]
19. Current advances in the algae-made biopharmaceuticals field.
Rosales-Mendoza S; Solís-Andrade KI; Márquez-Escobar VA; González-Ortega O; Bañuelos-Hernandez B
Expert Opin Biol Ther; 2020 Jul; 20(7):751-766. PubMed ID: 32142617
[TBL] [Abstract][Full Text] [Related]
20. Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals.
Nguyen HX; Nguyen CN
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
